Why the study?
Does early initiation of Impella 2.5 prior to PCI improve survival and revascularization in patients with refractory cardiogenic shock complicating an acute myocardial infarction?
Does early initiation of Impella 2.5 prior to PCI improve survival and revascularization in patients with refractory cardiogenic shock complicating an acute myocardial infarction?
Early initiation of Impella 2.5 prior to PCI in patients with AMI and refractory cardiogenic shock is associated with improved survival and more complete revascularization.
May support early Impella in refractory AMI shock; leaves open confirmation by randomized trials.
The results of our study suggest that early initiation of hemodynamic support prior to PCI with Impella 2.5 is associated with more complete revascularization and improved survival in the setting of refractory CS complicating an AMI.
No takes yet. Share an insight, caveat, or question.
O’Neill et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: